Skip to main content
SHANGHAI MICROPORT EP MEDTECH CO., LTD. logo

SHANGHAI MICROPORT EP MEDTECH CO., LTD. — Investor Relations & Filings

Ticker · 688351 ISIN · CNE100005PG9 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 362 across all filing types
Latest filing 2023-09-14 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 688351

About SHANGHAI MICROPORT EP MEDTECH CO., LTD.

https://www.everpace.com/

SHANGHAI MICROPORT EP MEDTECH CO., LTD. focuses on the research, development, and commercialization of medical devices for cardiac electrophysiology. The company provides a comprehensive suite of products for the diagnosis and treatment of cardiac arrhythmias, including 3D cardiac mapping systems, diagnostic catheters, and radiofrequency ablation catheters. Its core technology, the Columbus 3D EP Navigation System, enables precise localization and visualization of catheters within the heart. The product line also encompasses irrigation pumps and ablation generators designed to support minimally invasive procedures. The company aims to deliver integrated solutions that improve clinical outcomes for patients with rhythm disorders through advanced mapping and therapeutic technologies.

Recent filings

Filing Released Lang Actions
关于中证中小投资者服务中心《股东质询函》的回复公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from Shanghai MicroPort EP MedTech Co., Ltd. responding to a shareholder inquiry regarding an investment and related-party transaction involving an equity investment in Shanghai Shangyang Medical Technology Co., Ltd. It includes extensive disclosure about the valuation methodology, financial data, business prospects, and related agreements. The content focuses on a capital investment transaction, valuation justification, and related-party disclosures. It is not a full annual or interim financial report, nor an earnings release or audit report. It is not a simple announcement of a report publication but a substantive disclosure about a financing-related transaction. Therefore, the document fits best under the category of Capital/Financing Update (CAP). The document length and detail support a high confidence classification as CAP.
2023-09-14 Chinese
华泰联合证券有限责任公司关于上海微创电生理医疗科技股份有限公司首次公开发行部分限售股上市流通的核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed verification opinion from a securities company regarding the listing and circulation of restricted shares following an initial public offering (IPO) of Shanghai MicroPort EP MedTech Co., Ltd. It includes specifics about the types and quantities of restricted shares, shareholder commitments, compliance with relevant laws and regulations, and the securities company's conclusion on the matter. The document is not a financial report, earnings release, or management discussion, but rather a formal verification or audit opinion related to share circulation post-IPO. It does not announce a vote result, nor is it a proxy or governance document. It is a standalone audit-type report focusing on compliance and verification of share circulation conditions. Therefore, it fits best under the category of Audit Report / Information (AR). The document length is under 5,000 characters, but it contains substantive content and is not merely an announcement of a report publication, so it is not RPA or RNS. Hence, the classification is AR with high confidence. Q3 2023
2023-09-08 Chinese
关于首次公开发行部分限售股上市流通的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from Shanghai MicroPort EP MedTech Co., Ltd. regarding the listing and circulation of a portion of restricted shares following the company's initial public offering (IPO). It details the number of shares becoming freely tradable, the lock-up period, shareholder commitments, and compliance with regulatory requirements. The document includes a verification opinion from an intermediary institution and specific dates related to the share circulation. There is no financial statement or detailed financial performance data, nor is it a report or presentation. The content is focused on the announcement of the unlocking and circulation of restricted shares post-IPO, which fits the category of a Regulatory Filing (RNS) as it is a regulatory announcement about share circulation and compliance rather than a financial report or capital raising update. The document length is under 5,000 characters, and it is a formal announcement rather than a report itself.
2023-09-08 Chinese
华泰联合证券有限责任公司关于上海微创电生理医疗科技股份有限公司2023年半年度持续督导跟踪报告
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "2023年半年度持续督导跟踪报告" which translates to "2023 Semi-Annual Continuous Supervision Follow-up Report". It is issued by the sponsor (华泰联合证券有限责任公司) for the company 上海微创电生理医疗科技股份有限公司. The content includes detailed financial data for the first half of 2023, risk factors, core competitiveness, R&D progress, and usage of raised funds. It also discusses compliance with regulatory requirements and includes information about shareholdings and management changes. The document is comprehensive and contains substantive financial data and analysis for a half-year period, indicating it is an interim or quarterly report rather than a simple announcement or certification. It is not a full annual report (10-K), nor is it a short earnings release or a regulatory filing. The document fits the definition of an Interim / Quarterly Report (IR) as it covers a period shorter than a full fiscal year with detailed financial statements and analysis. H1 2023
2023-09-07 Chinese
2023年第一次临时股东大会会议资料
AGM Information Classification · 95% confidence The document is titled as "2023 年第一次临时股东大会会议资料" which translates to "2023 First Extraordinary General Meeting (EGM) Meeting Materials." It contains detailed meeting agenda, voting procedures, proposals to be discussed and voted on, and information about board member changes. The content is clearly materials prepared for a shareholders meeting, including proposals on fund usage, investment, and board member election. There is no financial statement or earnings data, nor is it a transcript or announcement of results. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual or Extraordinary General Meeting. The document length is about 5073 characters, which is consistent with a meeting material document rather than a brief announcement or a full annual report. Therefore, the correct classification is AGM Information (AGM-R).
2023-09-07 Chinese
关于一次性使用压力监测磁定位射频消融导管获得欧盟MDA认证和英国MDR认证的自愿披露公告
Regulatory Filings Classification · 95% confidence The document is a voluntary disclosure announcement by Shanghai MicroPort EP MedTech Co., Ltd. regarding the certification of a medical device product under the EU Medical Device Regulations (MDR) and UK MDR. It details certification numbers, issuing bodies, product description, and the impact on the company. The document is short (1164 characters) and does not contain financial data, earnings, or management discussion. It is an announcement about regulatory certification and its potential impact, not a financial report or detailed management report. It does not fit into categories like Annual Report, Earnings Release, or Management Reports. It is a regulatory announcement about product certification, which aligns best with Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-08-31 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.